Our findings of upregulation of HSP 60 and TAK1-TAB1 in CAD patients compared to HC, along with their negative correlation with LDL cholesterol levels in HC patients, suggest potential roles for these proteins in atherosclerosis and dyslipidemia. This evidence concerns the gene MAP3K7 and atherosclerosis.